Dr. Mauro M. Sette is the Founder and Chief Executive Officer of Medyria, a Swiss medtech company advancing next‑generation sensing technologies for cardiovascular care. He is a biomedical engineer by training, with a strong background in medical devices, surgical robotics, and catheter‑based technologies. Under his leadership, Medyria has developed proprietary blood‑flow velocity sensing solutions, including the flagship PyCath system for interventional cardiology. Dr. Sette has successfully guided the company from early research through clinical development, regulatory milestones, and international growth, backed by leading European investors.